Historical snapshot from Q2 2024.View current holdings →
In Q2 2024, Deerfield Management held 251 positions worth $4.3B. They initiated 127 new positions and exited 214. Their largest holding was NUVL ($1.5B). Portfolio value grew +1.4% versus the prior quarter.
Portfolio Value (13F)
$4.3B
Holdings
251
Top 10 Concentration
63.5%
QoQ Change
+1.4%
Turnover
9.2%
Sector Breakdown
Biotechnology88%(205)
Other Healthcare12%(46)
Q2 2024 Holdings (251)
| # | Ticker | Company | Change | Value | % of Portfolio | SI % Float ? |
|---|---|---|---|---|---|---|
| 1 | NUVL | Nuvalent Inc. | $1.5B | 35.26% | 6.2% | |
| 2 | VTRS | Viatris Inc. | Held | $227.4M | 5.29% | 3.7% |
| 3 | LRMR | Larimar Therapeutics, Inc. | $153.9M | 3.58% | 22.9% | |
| 4 | CPRX | Catalyst Pharmaceuticals Inc. | Held | $141.4M | 3.29% | 8.3% |
| 5 | AHCO | AdaptHealth Corp. | $132.6M | 3.08% | 9.6% | |
| 6 | RVMD | Revolution Medicines Inc. | $119.9M | 2.79% | 5.9% | |
| 7 | SGRYOther Healthcare | Surgery Partners, Inc. | Increased | $112.0M | 2.60% | 21.7% |
| 8 | KURA | Kura Oncology, Inc. | $111.4M | 2.59% | 16.6% | |
| 9 | OSCR | Oscar Health, Inc. | Decreased | $110.1M | 2.56% | 6.5% |
| 10 | WAYOther Healthcare | Waystar Holding Corp. | New | $106.5M | 2.48% | 9.6% |
| 11 | GILD | Gilead Sciences Inc. | New | $102.3M | 2.38% | 1.8% |
| 12 | NBIX | Neurocrine Biosciences Inc. | $95.1M | 2.21% | 7.5% | |
| 13 | SPRY | ARS Pharmaceuticals, Inc. | $94.3M | 2.19% | 30.7% | |
| 14 | ALHC | Alignment Healthcare, Inc. | Increased | $85.3M | 1.98% | 11.7% |
| 15 | IDYA | IDEAYA Biosciences Inc. | Decreased | $73.6M | 1.71% | 11.1% |
| 16 | CVSOther Healthcare | Cvs Health Corp. | New | $57.6M | 1.34% | 1.3% |
| 17 | CGEM | Cullinan Therapeutics, Inc. | Increased | $57.2M | 1.33% | 16.5% |
| 18 | EWTX | Edgewise Therapeutics, Inc. | $51.8M | 1.20% | 14.6% | |
| 19 | BCRX | Biocryst Pharmaceuticals Inc. | Increased | $50.3M | 1.17% | 10.8% |
| 20 | BNTX | BioNTech SE | Increased | $47.7M | 1.11% | 3.7% |
| 21 | IRON | Disc Medicine Inc. | Increased | $46.1M | 1.07% | 22.1% |
| 22 | EHABOther Healthcare | Enhabit, Inc. | $44.6M | 1.04% | 2.4% | |
| 23 | CNMDOther Healthcare | Conmed Corp. | Increased | $43.8M | 1.02% | 7.8% |
| 24 | DAWN | Day One Biopharmaceuticals Inc. | Increased | $40.3M | 0.94% | 7.5% |
| 25 | GLPGF | Galapagos NV | $35.0M | 0.81% | — | |
| 26 | EMBCOther Healthcare | Embecta Corp. | $34.1M | 0.79% | 12.4% | |
| 27 | GPCR | Structure Therapeutics Inc. | Decreased | $33.2M | 0.77% | 14.5% |
| 28 | COGT | Cogent Biosciences Inc. | Increased | $31.6M | 0.73% | 11.3% |
| 29 | ALNY | Alnylam Pharmaceuticals Inc. | Increased | $29.1M | 0.68% | 7.7% |
| 30 | PHVS | Pharvaris N.V. | Increased | $26.3M | 0.61% | 3.5% |
| 31 | MREO | Mereo BioPharma Group plc | New | $24.2M | 0.56% | 2.1% |
| 32 | PODDOther Healthcare | Insulet Corp. | Increased | $22.7M | 0.53% | 8.7% |
| 33 | NKTX | Nkarta, Inc. | Decreased | $22.5M | 0.52% | 6.4% |
| 34 | DCGOOther Healthcare | DocGo Inc. | Increased | $22.2M | 0.52% | 2.1% |
| 35 | INMDOther Healthcare | InMode Ltd. | $21.3M | 0.49% | 4.4% | |
| 36 | PACSOther Healthcare | PACS Group, Inc. | New | $19.6M | 0.46% | 8.6% |
| 37 | LNTH | Lantheus Holdings Inc. | Held | $19.3M | 0.45% | 6.8% |
| 38 | CSTL | Castle Biosciences Inc. | Decreased | $19.0M | 0.44% | 6.7% |
| 39 | NAMSW | NewAmsterdam Pharma Co N.V. | Increased | $17.5M | 0.41% | — |
| 40 | PRLD | Prelude Therapeutics Inc. | $15.7M | 0.37% | 18.1% | |
| 41 | KYTX | Kyverna Therapeutics, Inc. | Increased | $14.9M | 0.35% | 18.3% |
| 42 | FHTX | Foghorn Therapeutics Inc. | Increased | $14.5M | 0.34% | 6.6% |
| 43 | CGON | CG Oncology, Inc. | Increased | $13.7M | 0.32% | 12.0% |
| 44 | TNGX | Tango Therapeutics Inc. | $13.2M | 0.31% | 26.7% | |
| 45 | APGE | Apogee Therapeutics Inc. | $12.9M | 0.30% | 7.3% | |
| 46 | AUTL | Autolus Therapeutics plc | $12.7M | 0.29% | 4.9% | |
| 47 | ACCDOther Healthcare | Accolade Inc. | Increased | $12.4M | 0.29% | — |
| 48 | FATE | Fate Therapeutics Inc. | Increased | $11.7M | 0.27% | 10.1% |
| 49 | TXG | 10x Genomics Inc. | New | $11.6M | 0.27% | 17.3% |
| 50 | ITOS | iTeos Therapeutics SA | $10.7M | 0.25% | — | |
| 51 | SLDB | Solid Biosciences Inc. | Decreased | $9.9M | 0.23% | 13.5% |
| 52 | EYPT | EyePoint, Inc. | Increased | $7.6M | 0.18% | 25.4% |
| 53 | ALEC | Alector Inc. | Increased | $5.2M | 0.12% | 5.8% |
| 54 | PRME | Prime Medicine, Inc. | Increased | $4.6M | 0.11% | 22.6% |
| 55 | PHR | Phreesia, Inc. | New | $4.1M | 0.09% | 6.0% |
| 56 | CALC | CalciMedica, Inc. | $4.0M | 0.09% | 2.3% | |
| 57 | CABA | Cabaletta Bio, Inc. | Decreased | $3.5M | 0.08% | 25.1% |
| 58 | UTI | Universal Technical Institute Inc. | Increased | $3.3M | 0.08% | 13.9% |
| 59 | ANNX | Annexon Biosciences Inc. | $2.9M | 0.07% | 17.9% | |
| 60 | JBL | Jabil Inc. | New | $2.1M | 0.05% | 3.2% |
| 61 | PHGE | BiomX Inc. | $2.1M | 0.05% | 2.3% | |
| 62 | ZTS | Zoetis Inc. | Increased | $1.7M | 0.04% | 5.0% |
| 63 | INOD | Innodata Inc. | Increased | $1.7M | 0.04% | 14.1% |
| 64 | TOIIWOther Healthcare | Oncology Institute, Inc. | $1.6M | 0.04% | — | |
| 65 | HUMAW | Humacyte, Inc. | New | $1.6M | 0.04% | — |
| 66 | RSMDF | Resmed Inc. | Increased | $1.4M | 0.03% | — |
| 67 | INTU | Intuit Inc. | New | $1.4M | 0.03% | 3.1% |
| 68 | TMDXOther Healthcare | TransMedics Group, Inc. | New | $1.4M | 0.03% | 38.4% |
| 69 | NCRRP | NCR Voyix Corp. | New | $1.3M | 0.03% | — |
| 70 | NVDA | Nvidia Corp. | Increased | $1.3M | 0.03% | 1.3% |
| 71 | RVTYOther Healthcare | Revvity, Inc. | Increased | $1.3M | 0.03% | 8.5% |
| 72 | XRAYOther Healthcare | Dentsply Sirona Inc. | Increased | $1.2M | 0.03% | 14.3% |
| 73 | AMAL | Amalgamated Financial Corp. | New | $1.2M | 0.03% | 7.8% |
| 74 | AROC | Archrock, Inc. | Increased | $1.2M | 0.03% | 5.5% |
| 75 | TORO | Toro Corp. | New | $1.2M | 0.03% | 0.4% |
| 76 | KMT | Kennametal Inc. | New | $1.2M | 0.03% | 14.3% |
| 77 | MMS | Maximus, Inc. | Increased | $1.2M | 0.03% | 11.6% |
| 78 | TFXOther Healthcare | Teleflex Inc. | New | $1.2M | 0.03% | 15.0% |
| 79 | SNOW | Snowflake Inc. | New | $1.1M | 0.03% | 5.2% |
| 80 | VRSK | Verisk Analytics, Inc. | Increased | $1.1M | 0.03% | 3.7% |
| 81 | OTTR | Otter Tail Corp. | New | $1.1M | 0.03% | 16.3% |
| 82 | CAG | Conagra Brands Inc. | New | $1.1M | 0.02% | 10.6% |
| 83 | FLS | Flowserve Corp. | Increased | $1.0M | 0.02% | 7.2% |
| 84 | MNKD | MannKind Corporation | Increased | $1.0M | 0.02% | 8.2% |
| 85 | CBIO | Crescent Biopharma, Inc. | New | $1.0M | 0.02% | 22.1% |
| 86 | HOLXOther Healthcare | Hologic Inc. | New | $1.0M | 0.02% | 3.7% |
| 87 | NHC | National Healthcare Corp. | Increased | $974K | 0.02% | 6.4% |
| 88 | VREXOther Healthcare | Varex Imaging Corp. | New | $971K | 0.02% | 4.4% |
| 89 | TECH | Bio-Techne Corporation | New | $969K | 0.02% | 4.7% |
| 90 | TWST | Twist Bioscience Corporation | New | $959K | 0.02% | 20.1% |
| 91 | DLTR | Dollar Tree, Inc. | New | $952K | 0.02% | 4.8% |
| 92 | PSMT | Pricesmart Inc. | New | $934K | 0.02% | 9.7% |
| 93 | HSY | Hershey CO | New | $925K | 0.02% | 7.2% |
| 94 | UBER | Uber Technologies, Inc. | New | $924K | 0.02% | 2.5% |
| 95 | AGYS | Agilysys Inc. | Increased | $911K | 0.02% | 7.4% |
| 96 | BX | Blackstone Inc. | New | $905K | 0.02% | 3.0% |
| 97 | HCIIP | HCI Group, Inc. | Increased | $901K | 0.02% | — |
| 98 | MU | Micron Technology Inc. | Increased | $893K | 0.02% | 2.3% |
| 99 | CTKBOther Healthcare | Cytek Biosciences, Inc. | New | $869K | 0.02% | 5.1% |
| 100 | HSICOther Healthcare | Henry Schein Inc. | New | $864K | 0.02% | 9.0% |
| 101 | LRCX | Lam Research Corp. | New | $855K | 0.02% | 2.3% |
| 102 | CMS-PC | Cms Energy Corp. | New | $854K | 0.02% | — |
| 103 | ULTA | Ulta Beauty, Inc. | Increased | $845K | 0.02% | 5.7% |
| 104 | SITM | Sitime Corp. | New | $819K | 0.02% | 7.5% |
| 105 | CBT | Cabot Corp. | New | $819K | 0.02% | 11.7% |
| 106 | SLP | Simulations Plus, Inc. | New | $811K | 0.02% | 24.6% |
| 107 | BMRN | BioMarin Pharmaceutical Inc. | New | $809K | 0.02% | 6.0% |
| 108 | NTNX | Nutanix, Inc. | New | $808K | 0.02% | 6.0% |
| 109 | NUVB | Nuvation Bio Inc. | Increased | $793K | 0.02% | 27.6% |
| 110 | VEEV | Veeva Systems Inc. | Increased | $785K | 0.02% | 3.3% |
| 111 | GTLS | Chart Industries Inc. | Increased | $780K | 0.02% | 10.9% |
| 112 | TMUSL | T-Mobile US, Inc. | New | $764K | 0.02% | — |
| 113 | INSM | Insmed Incorporated | Increased | $761K | 0.02% | 7.1% |
| 114 | MRCY | Mercury Systems Inc. | Increased | $730K | 0.02% | 9.5% |
| 115 | CMC | Commercial Metals Co | New | $721K | 0.02% | 7.5% |
| 116 | AXP | American Express CO | Decreased | $719K | 0.02% | 2.1% |
| 117 | WMT | Walmart Inc. | Increased | $703K | 0.02% | 1.8% |
| 118 | TXRH | Texas Roadhouse, Inc. | New | $696K | 0.02% | 3.5% |
| 119 | SEDG | Solaredge Technologies, Inc. | New | $678K | 0.02% | 21.0% |
| 120 | DCI | Donaldson Co Inc. | New | $672K | 0.02% | 3.3% |
| 121 | LGNZZ | Ligand Pharmaceuticals Inc. | New | $667K | 0.02% | — |
| 122 | HD | Home Depot, Inc. | New | $662K | 0.02% | 1.3% |
| 123 | ADMA | ADMA Biologics Inc. | Decreased | $662K | 0.02% | 11.3% |
| 124 | FAST | Fastenal CO | Increased | $652K | 0.02% | 3.4% |
| 125 | CAT | Caterpillar Inc. | New | $651K | 0.02% | 1.9% |
| 126 | CLSKW | Cleanspark, Inc. | New | $646K | 0.02% | — |
| 127 | LEA | Lear Corp. | New | $635K | 0.01% | 8.4% |
| 128 | NXST | Nexstar Media Group, Inc. | New | $634K | 0.01% | 12.5% |
| 129 | IAC | Iac Inc. | New | $625K | 0.01% | 19.0% |
| 130 | LTH | Life Time Group Holdings, Inc. | Increased | $620K | 0.01% | 8.3% |
| 131 | BRBR | Bellring Brands, Inc. | Increased | $618K | 0.01% | 12.1% |
| 132 | VRTX | Vertex Pharmaceuticals Inc. | New | $598K | 0.01% | 2.0% |
| 133 | HUBG | Hub Group, Inc. | New | $592K | 0.01% | 10.3% |
| 134 | PRLB | Proto Labs Inc. | New | $591K | 0.01% | 4.3% |
| 135 | ALB-PA | Albemarle Corp. | New | $591K | 0.01% | — |
| 136 | NRIX | Nurix Therapeutics Inc. | Increased | $574K | 0.01% | 16.3% |
| 137 | ABSI | Absci Corp. | Increased | $564K | 0.01% | 26.6% |
| 138 | BA-PA | Boeing CO | Increased | $560K | 0.01% | — |
| 139 | CNXC | Concentrix Corp. | New | $556K | 0.01% | 17.6% |
| 140 | EHCOther Healthcare | Encompass Health Corp. | New | $541K | 0.01% | 4.0% |
| 141 | DOCSOther Healthcare | Doximity Inc. | New | $540K | 0.01% | 9.1% |
| 142 | RXSTOther Healthcare | RxSight Inc. | Increased | $538K | 0.01% | 10.4% |
| 143 | ONTO | Onto Innovation Inc. | New | $535K | 0.01% | 7.7% |
| 144 | PLUS | Eplus Inc. | New | $533K | 0.01% | 6.4% |
| 145 | HROW | Harrow, Inc. | Increased | $532K | 0.01% | 23.0% |
| 146 | MCKOther Healthcare | Mckesson Corp. | New | $527K | 0.01% | 2.0% |
| 147 | PAYO | Payoneer Global Inc. | Increased | $522K | 0.01% | 5.5% |
| 148 | PRCTOther Healthcare | PROCEPT BioRobotics Corp. | New | $515K | 0.01% | 13.3% |
| 149 | THCOther Healthcare | Tenet Healthcare Corp. | New | $511K | 0.01% | 2.7% |
| 150 | AN | Autonation, Inc. | New | $511K | 0.01% | 13.4% |
| 151 | ARWR | Arrowhead Pharmaceuticals Inc. | New | $506K | 0.01% | 10.6% |
| 152 | PCRX | Pacira BioSciences Inc. | Increased | $488K | 0.01% | 29.1% |
| 153 | CHWY | Chewy, Inc. | Decreased | $486K | 0.01% | 13.7% |
| 154 | NEO | Neogenomics Inc. | Increased | $481K | 0.01% | 13.0% |
| 155 | SRI | Stoneridge Inc. | New | $472K | 0.01% | 3.3% |
| 156 | EXEL | Exelixis Inc. | Increased | $468K | 0.01% | 15.6% |
| 157 | DBX | Dropbox, Inc. | New | $468K | 0.01% | 29.9% |
| 158 | LOPE | Grand Canyon Education, Inc. | New | $463K | 0.01% | 9.0% |
| 159 | QLYS | Qualys, Inc. | New | $458K | 0.01% | 13.1% |
| 160 | LYFT | Lyft, Inc. | New | $458K | 0.01% | 21.0% |
| 161 | PGNYOther Healthcare | Progyny Inc. | Increased | $452K | 0.01% | 9.4% |
| 162 | ADPT | Adaptive Biotechnologies Corporation | Increased | $445K | 0.01% | 9.4% |
| 163 | APPN | Appian Corp. | New | $433K | 0.01% | 12.9% |
| 164 | BL | Blackline, Inc. | New | $430K | 0.01% | 14.3% |
| 165 | COLL | Collegium Pharmaceutical, Inc. | Increased | $428K | 0.01% | 20.2% |
| 166 | RGENOther Healthcare | Repligen Corporation | New | $424K | 0.01% | 13.5% |
| 167 | STAAOther Healthcare | Staar Surgical CO | New | $423K | 0.01% | 15.6% |
| 168 | UUUU | Energy Fuels Inc. | New | $422K | 0.01% | 21.4% |
| 169 | APTV | Aptiv PLC | Decreased | $421K | 0.01% | 6.1% |
| 170 | UCTT | Ultra Clean Holdings, Inc. | New | $414K | 0.01% | 11.0% |
| 171 | SBRA | Sabra Health Care REIT, Inc. | New | $411K | 0.01% | 10.7% |
| 172 | CRM | Salesforce, Inc. | New | $409K | 0.01% | 4.6% |
| 173 | FTNT | Fortinet, Inc. | Decreased | $391K | 0.01% | 2.1% |
| 174 | ATRCOther Healthcare | AtriCure, Inc. | Decreased | $389K | 0.01% | 9.9% |
| 175 | PH | Parker-Hannifin Corp. | New | $384K | 0.01% | 1.2% |
| 176 | AQST | Aquestive Therapeutics, Inc. | New | $380K | 0.01% | 24.0% |
| 177 | MELI | Mercadolibre Inc. | New | $378K | 0.01% | 1.8% |
| 178 | INSPOther Healthcare | Inspire Medical Systems, Inc. | New | $376K | 0.01% | 19.0% |
| 179 | BLKB | Blackbaud Inc. | New | $372K | 0.01% | 11.6% |
| 180 | COIN | Coinbase Global, Inc. | New | $370K | 0.01% | 11.1% |
| 181 | SPGI | S&P Global Inc. | New | $364K | 0.01% | 2.2% |
| 182 | MAX | MediaAlpha, Inc. | New | $364K | 0.01% | 9.4% |
| 183 | DLB | Dolby Laboratories, Inc. | New | $363K | 0.01% | 13.4% |
| 184 | AVXL | Anavex Life Sciences Corp. | Increased | $346K | 0.01% | 14.9% |
| 185 | OLMA | Olema Pharmaceuticals, Inc. | New | $340K | 0.01% | 20.4% |
| 186 | IT | Gartner Inc. | New | $339K | 0.01% | 15.6% |
| 187 | RILYZ | BRC Group Holdings, Inc. | New | $335K | 0.01% | — |
| 188 | RILYT | BRC Group Holdings, Inc. | New | $335K | 0.01% | — |
| 189 | ON | ON Semiconductor Corp. | New | $327K | 0.01% | 10.6% |
| 190 | ANIP | Ani Pharmaceuticals Inc. | Increased | $327K | 0.01% | 18.5% |
| 191 | SDGR | Schrodinger Inc. | New | $318K | 0.01% | 24.1% |
| 192 | HNRG | Hallador Energy CO | Increased | $318K | 0.01% | 10.4% |
| 193 | OTIS | Otis Worldwide Corp. | New | $313K | 0.01% | 5.2% |
| 194 | BRZE | Braze, Inc. | New | $311K | 0.01% | 8.0% |
| 195 | TRIBOther Healthcare | Trinity Biotech Plc | Increased | $310K | 0.01% | 5.6% |
| 196 | EXTR | Extreme Networks Inc. | New | $310K | 0.01% | 7.0% |
| 197 | RLAY | Relay Therapeutics Inc. | New | $304K | 0.01% | 24.8% |
| 198 | MOHOther Healthcare | Molina Healthcare, Inc. | New | $303K | 0.01% | 6.4% |
| 199 | LUNGOther Healthcare | Pulmonx Corporation | Increased | $301K | 0.01% | 2.2% |
| 200 | LMT | Lockheed Martin Corp. | Increased | $300K | 0.01% | 1.4% |
| 201 | OPCHOther Healthcare | Option Care Health, Inc. | New | $300K | 0.01% | 8.0% |
| 202 | LENZ | LENZ Therapeutics, Inc. | New | $300K | 0.01% | 55.3% |
| 203 | FFIV | F5, Inc. | New | $296K | 0.01% | 3.0% |
| 204 | KRYS | Krystal Biotech Inc. | Increased | $295K | 0.01% | 19.2% |
| 205 | FOLD | Amicus Therapeutics Inc. | Increased | $295K | 0.01% | 7.0% |
| 206 | FHN-PH | First Horizon Corp. | New | $292K | 0.01% | — |
| 207 | WWD | Woodward, Inc. | Increased | $287K | 0.01% | 2.1% |
| 208 | KMX | Carmax Inc. | Increased | $285K | 0.01% | 8.6% |
| 209 | QTRX | Quanterix Corp. | New | $284K | 0.01% | 12.0% |
| 210 | WCN | Waste Connections, Inc. | New | $281K | 0.01% | 1.8% |
| 211 | PTON | Peloton Interactive, Inc. | New | $281K | 0.01% | 16.1% |
| 212 | ADUSOther Healthcare | Addus HomeCare Corp. | New | $279K | 0.01% | 6.0% |
| 213 | AKRO | Akero Therapeutics Inc. | Decreased | $278K | 0.01% | — |
| 214 | CPAY | Corpay, Inc. | New | $277K | 0.01% | 5.5% |
| 215 | TARS | Tarsus Pharmaceuticals Inc. | Increased | $273K | 0.01% | 13.4% |
| 216 | REPL | Replimune Group Inc. | Decreased | $264K | 0.01% | 34.2% |
| 217 | VSOGF | Vista Energy, S.A.B. de C.V. | New | $262K | 0.01% | — |
| 218 | DXC | DXC Technology Co | Decreased | $260K | 0.01% | 19.0% |
| 219 | CPRT | Copart Inc. | New | $258K | 0.01% | 3.9% |
| 220 | UNHOther Healthcare | Unitedhealth Group Inc. | $250K | 0.01% | 2.0% | |
| 221 | KMPB | Kemper Corp. | New | $250K | 0.01% | — |
| 222 | MTRN | Materion Corp. | New | $247K | 0.01% | 4.0% |
| 223 | HOOD | Robinhood Markets, Inc. | New | $246K | 0.01% | 5.1% |
| 224 | CIOther Healthcare | Cigna Group | New | $244K | 0.01% | 2.9% |
| 225 | CVX | Chevron Corp. | New | $244K | 0.01% | 1.2% |
| 226 | GOOG | Alphabet Inc. | Decreased | $244K | 0.01% | — |
| 227 | FWRD | Forward Air Corp. | Increased | $242K | 0.01% | 9.4% |
| 228 | CYTK | Cytokinetics Incorporated | Decreased | $237K | 0.01% | 21.2% |
| 229 | MRVL | Marvell Technology, Inc. | Decreased | $235K | 0.01% | 3.2% |
| 230 | OPLN | Openlane, Inc. | Increased | $233K | 0.01% | 2.2% |
| 231 | MASIOther Healthcare | Masimo Corporation | New | $233K | 0.01% | 7.3% |
| 232 | VERA | Vera Therapeutics Inc. | Decreased | $224K | 0.01% | 27.2% |
| 233 | BIIB | Biogen Inc. | New | $216K | 0.01% | 4.5% |
| 234 | VC | Visteon Corp. | Decreased | $213K | 0.00% | 18.0% |
| 235 | RIOT | Riot Platforms, Inc. | New | $213K | 0.00% | 13.9% |
| 236 | CTRN | Citi Trends Inc. | New | $208K | 0.00% | 25.6% |
| 237 | MTSI | MACOM Technology Solutions Holdings, Inc. | New | $207K | 0.00% | 5.0% |
| 238 | CYRX | Cryoport, Inc. | New | $207K | 0.00% | 5.6% |
| 239 | TALKOther Healthcare | Talkspace Inc. | New | $204K | 0.00% | 3.8% |
| 240 | XMTR | Xometry, Inc. | New | $203K | 0.00% | 9.6% |
| 241 | KIDSOther Healthcare | Orthopediatrics Corp. | Increased | $203K | 0.00% | 5.2% |
| 242 | ARLO | Arlo Technologies, Inc. | New | $184K | 0.00% | 13.7% |
| 243 | GDRXOther Healthcare | GoodRx Holdings Inc. | New | $173K | 0.00% | 4.3% |
| 244 | FSLY | Fastly, Inc. | Decreased | $168K | 0.00% | 15.5% |
| 245 | TDOCOther Healthcare | Teladoc Health, Inc. | New | $166K | 0.00% | 16.6% |
| 246 | SIBNOther Healthcare | Si-Bone, Inc. | New | $151K | 0.00% | 13.3% |
| 247 | NUS | NU Skin Enterprises, Inc. | New | $142K | 0.00% | 9.7% |
| 248 | KALV | KalVista Pharmaceuticals, Inc. | Decreased | $128K | 0.00% | 14.4% |
| 249 | PLRX | Pliant Therapeutics Inc. | New | $126K | 0.00% | 7.0% |
| 250 | HCATOther Healthcare | Health Catalyst, Inc. | Decreased | $86K | 0.00% | 3.6% |
| 251 | BFLYOther Healthcare | Butterfly Network, Inc. | $17K | 0.00% | 14.8% |
Top Movers This Quarter
Share changes reflect active decisions. Value changes include price moves.
Frequently asked questions
What stocks did Deerfield Management own in Q2 2024?
Deerfield Management held 251 biotech stocks in their 13F portfolio in Q2 2024. Their top positions include NUVL, VTRS, LRMR, CPRX, AHCO. The full holdings table is available on BiotechEdge with position sizes, quarter-over-quarter changes, and AI analysis.
How much was Deerfield Management's portfolio worth in Q2 2024?
Deerfield Management's tracked biotech portfolio was worth $4.3B across 251 positions, with total assets under management of approximately $16B. Portfolio values are based on 13F filings with the SEC.
What did Deerfield Management buy in Q2 2024?
Deerfield Management initiated 127 new positions in Q2 2024, including WAY, GILD, CVS, MREO, PACS and 122 more. They also increased 76 existing positions.
What did Deerfield Management sell in Q2 2024?
Deerfield Management fully exited 214 positions in Q2 2024, including WRB-PH, MRNA, MET-PF, MRSN, MBI and 209 more. They also trimmed 25 existing positions.
Is Deerfield Management a biotech fund?
Multi-strategy healthcare fund with one of the longest track records in the space. Deerfield invests across public equity, private equity, structured credit, and royalties in healthcare. Known for creative financing structures and deep industry relationships across pharma and biotech.
Want AI analysis, insider signals, and catalyst overlays for Deerfield Management?
View latest Deerfield Management portfolio →